Current treatment of atypical hemolytic uremic syndrome

Tremendous advances have been made in understanding the pathogenesis of atypical Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular biology of aHUS resulted in rapid advances in treatment with eculizumab (Soliris(®), Alexion Pharmaceuticals Inc.). Historically,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kaplan, Bernard S., Ruebner, Rebecca L., Spinale, Joann M., Copelovitch, Lawrence
Format: Artigo
Sprog:Inglês
Udgivet: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2014
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204535/
https://ncbi.nlm.nih.gov/pubmed/25343125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2014.01001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker